Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 18.04
(0.33%)
HKD 18.04
(0.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.9 Billion CNY | 78.57% |
| 2022 | 2.18 Billion CNY | 74.73% |
| 2021 | 1.25 Billion CNY | 18.04% |
| 2020 | 1.05 Billion CNY | 92.09% |
| 2019 | 551.49 Million CNY | 33.36% |
| 2018 | 413.55 Million CNY | 1950.16% |
| 2017 | 20.17 Million CNY | -39.79% |
| 2016 | 33.5 Million CNY | -15.73% |
| 2015 | 39.75 Million CNY | 77.78% |
| 2014 | 22.36 Million CNY | 159.19% |
| 2013 | 8.62 Million CNY | 95.04% |
| 2012 | 4.42 Million CNY | 0.0% |
| 2011 | 4.42 Million CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 4.44 Million CNY | -85.2% |
| 2008 | 30 Million CNY | 529.83% |
| 2007 | 4.76 Million CNY | 1.45% |
| 2006 | 4.69 Million CNY | -0.46% |
| 2005 | 4.71 Million CNY | -95.69% |
| 2004 | 109.5 Million CNY | 2.16% |
| 2003 | 107.18 Million CNY | 19.51% |
| 2002 | 89.68 Million CNY | 796.8% |
| 2001 | 10 Million CNY | -84.62% |
| 2000 | 65 Million CNY | 135.51% |
| 1999 | 27.6 Million CNY | -4.53% |
| 1998 | 28.91 Million CNY | -66.61% |
| 1997 | 86.58 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 3.79 Billion CNY | -7.26% |
| 2024 Q3 | 2.64 Billion CNY | -18.74% |
| 2024 Q1 | 4.06 Billion CNY | 5.6% |
| 2023 Q4 | 3.9 Billion CNY | 3.66% |
| 2023 Q3 | 3.76 Billion CNY | 7.82% |
| 2023 Q1 | 3.71 Billion CNY | 70.08% |
| 2023 FY | 3.9 Billion CNY | 78.57% |
| 2023 Q2 | 3.49 Billion CNY | -6.05% |
| 2022 Q3 | 2.22 Billion CNY | 27.51% |
| 2022 FY | 2.18 Billion CNY | 74.73% |
| 2022 Q4 | 2.18 Billion CNY | -1.94% |
| 2022 Q2 | 1.74 Billion CNY | 40.07% |
| 2022 Q1 | 1.24 Billion CNY | -0.23% |
| 2021 Q4 | 1.25 Billion CNY | -1.83% |
| 2021 Q2 | 1.29 Billion CNY | 20.27% |
| 2021 FY | 1.25 Billion CNY | 18.04% |
| 2021 Q3 | 1.27 Billion CNY | -1.46% |
| 2021 Q1 | 1.07 Billion CNY | 1.45% |
| 2020 Q1 | 563.47 Million CNY | 2.17% |
| 2020 Q3 | 1 Billion CNY | 75.17% |
| 2020 Q2 | 575.53 Million CNY | 2.14% |
| 2020 FY | 1.05 Billion CNY | 92.09% |
| 2020 Q4 | 1.05 Billion CNY | 5.08% |
| 2019 Q2 | 609.81 Million CNY | 178.45% |
| 2019 Q1 | 219 Million CNY | -47.04% |
| 2019 FY | 551.49 Million CNY | 33.36% |
| 2019 Q3 | 562.66 Million CNY | -7.73% |
| 2019 Q4 | 551.49 Million CNY | -1.99% |
| 2018 FY | 413.55 Million CNY | 1950.16% |
| 2018 Q4 | 413.55 Million CNY | -37.73% |
| 2018 Q3 | 664.15 Million CNY | -0.15% |
| 2018 Q2 | 665.15 Million CNY | 3185.37% |
| 2018 Q1 | 20.24 Million CNY | 0.37% |
| 2017 Q3 | 20.25 Million CNY | -1.49% |
| 2017 Q4 | 20.17 Million CNY | -0.4% |
| 2017 FY | 20.17 Million CNY | -39.79% |
| 2017 Q2 | 20.55 Million CNY | -38.17% |
| 2017 Q1 | 33.25 Million CNY | -0.75% |
| 2016 Q3 | 32.24 Million CNY | 0.74% |
| 2016 Q1 | 31.2 Million CNY | -21.5% |
| 2016 FY | 33.5 Million CNY | -15.73% |
| 2016 Q4 | 33.5 Million CNY | 3.9% |
| 2016 Q2 | 32 Million CNY | 2.57% |
| 2015 Q2 | 45.3 Million CNY | 102.61% |
| 2015 FY | 39.75 Million CNY | 77.78% |
| 2015 Q4 | 39.75 Million CNY | -16.31% |
| 2015 Q3 | 47.5 Million CNY | 4.84% |
| 2015 Q1 | 22.36 Million CNY | 0.0% |
| 2014 Q1 | 8.62 Million CNY | -0.0% |
| 2014 Q4 | 22.36 Million CNY | -0.24% |
| 2014 FY | 22.36 Million CNY | 159.19% |
| 2014 Q3 | 22.41 Million CNY | 159.82% |
| 2014 Q2 | 8.62 Million CNY | 0.0% |
| 2013 Q3 | 7.16 Million CNY | 309.15% |
| 2013 Q4 | 8.62 Million CNY | 20.47% |
| 2013 FY | 8.62 Million CNY | 95.04% |
| 2013 Q1 | 4.42 Million CNY | 0.0% |
| 2013 Q2 | 1.75 Million CNY | -60.43% |
| 2012 Q3 | 4.42 Million CNY | 0.0% |
| 2012 Q4 | 4.42 Million CNY | 0.0% |
| 2012 Q1 | 4.42 Million CNY | 0.0% |
| 2012 FY | 4.42 Million CNY | 0.0% |
| 2012 Q2 | 4.42 Million CNY | 0.0% |
| 2011 Q3 | 4.42 Million CNY | 0.0% |
| 2011 FY | 4.42 Million CNY | 0.0% |
| 2011 Q4 | 4.42 Million CNY | 0.0% |
| 2011 Q2 | 4.42 Million CNY | 0.0% |
| 2011 Q1 | 4.42 Million CNY | 0.0% |
| 2010 Q2 | 4.42 Million CNY | -0.1% |
| 2010 Q3 | 4.42 Million CNY | 0.0% |
| 2010 Q4 | 4.42 Million CNY | 0.0% |
| 2010 Q1 | 4.42 Million CNY | -0.29% |
| 2010 FY | - CNY | -100.0% |
| 2009 FY | 4.44 Million CNY | -85.2% |
| 2009 Q1 | 30 Million CNY | 0.0% |
| 2009 Q2 | 10 Million CNY | -66.67% |
| 2009 Q3 | 4.44 Million CNY | -55.55% |
| 2009 Q4 | 4.44 Million CNY | -0.09% |
| 2008 Q3 | 30 Million CNY | 530.9% |
| 2008 Q2 | 4.75 Million CNY | -0.33% |
| 2008 Q1 | 4.77 Million CNY | 0.17% |
| 2008 Q4 | 30 Million CNY | 0.0% |
| 2008 FY | 30 Million CNY | 529.83% |
| 2007 Q1 | - CNY | -100.0% |
| 2007 FY | 4.76 Million CNY | 1.45% |
| 2007 Q4 | 4.76 Million CNY | 0.0% |
| 2007 Q3 | - CNY | -100.0% |
| 2007 Q2 | 4.41 Million CNY | 0.0% |
| 2006 Q3 | 4.71 Million CNY | 0.0% |
| 2006 Q2 | 4.71 Million CNY | -0.04% |
| 2006 FY | 4.69 Million CNY | -0.46% |
| 2006 Q1 | 4.71 Million CNY | -0.0% |
| 2006 Q4 | 4.69 Million CNY | -0.42% |
| 2005 Q4 | 4.71 Million CNY | 0.46% |
| 2005 Q3 | 4.69 Million CNY | -84.35% |
| 2005 Q2 | 30 Million CNY | -72.6% |
| 2005 Q1 | 109.5 Million CNY | 0.0% |
| 2005 FY | 4.71 Million CNY | -95.69% |
| 2004 Q3 | 157.18 Million CNY | 23.59% |
| 2004 Q4 | 109.5 Million CNY | -30.33% |
| 2004 Q2 | 127.18 Million CNY | 0.0% |
| 2004 FY | 109.5 Million CNY | 2.16% |
| 2004 Q1 | 127.18 Million CNY | 18.66% |
| 2003 Q2 | 107.18 Million CNY | -8.53% |
| 2003 Q3 | 127.18 Million CNY | 18.66% |
| 2003 Q4 | 107.18 Million CNY | -15.73% |
| 2003 FY | 107.18 Million CNY | 19.51% |
| 2003 Q1 | 117.18 Million CNY | 30.66% |
| 2002 Q4 | 89.68 Million CNY | 113.52% |
| 2002 Q1 | 10 Million CNY | 0.0% |
| 2002 Q2 | 42 Million CNY | 320.0% |
| 2002 Q3 | 42 Million CNY | 0.0% |
| 2002 FY | 89.68 Million CNY | 796.8% |
| 2001 Q2 | 40 Million CNY | 0.0% |
| 2001 FY | 10 Million CNY | -84.62% |
| 2001 Q4 | 10 Million CNY | 0.0% |
| 2000 FY | 65 Million CNY | 135.51% |
| 2000 Q4 | 65 Million CNY | 0.0% |
| 1999 FY | 27.6 Million CNY | -4.53% |
| 1998 FY | 28.91 Million CNY | -66.61% |
| 1997 FY | 86.58 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -188125.386% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | -294.121% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -3231.435% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -1312.712% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -5423.968% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -10721.588% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -30381.293% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -4711.649% |
| SSY Group Limited | 1.94 Billion HKD | -100.348% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -8808.471% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | -558.884% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 76.518% |